©
HSJ
The partnership is delivering work to improve early and more precise diagnosis of Alzheimer’s Disease, with an emphasis on developments in Mental Health Trusts. Dementias Platform UK and Lilly UK collaborated on this together with 4 NHS Trusts enrolled from the DPUK Trials Delivery Framework in Greater Manchester Mental Health Foundation Trust, Oxford Health Foundation Trust, University Hospitals Sussex Foundation Trust, and Sheffield Teaching Hospital Foundation Trust.
It is an ambitious national collaborative pilot involving Lilly UK, Dementias Platform UK, and the NHS trusts, seeking to deliver earlier and more precise Alzheimer’s Disease diagnoses. Its further goal is to understand the costs and benefits in order to establish a framework for services across the NHS. Organisers believe that this transformative project has the potential to revolutionise the diagnostic landscape of AD in the UK, thereby improving outcomes for patients.